EUVIMEDEUVIMED entdecken
Crossref

Predictors of Incident High-Risk Varices in Patients with Hepatitis B-Related Cirrhosis Receiving Nucleos(t)ide Analog Therapy

Yu-Chia Chiu, Hsin-Ju Tsai, Chia-Chang Chen, Ying-Cheng Lin, Shou-Wu Lee, Teng-Yu Lee

Digestive Diseases · 16.07.2026 · 1-10

DOI: 10.1159/000553519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases, online erschienen am 16.07.2026. Verfasst von Yu-Chia Chiu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Liver Cirrhosis, Esophageal and Gastric Varices, Hepatitis B, Chronic, Nucleosides. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In patients receiving nucleos(t)ide analog (NA) therapy for chronic hepatitis B (CHB)-related cirrhosis, routine endoscopic surveillance may be deferred in the absence of high-risk varices (HRV). We aimed to identify predictors of incident HRV in this population.

Methods

This retrospective cohort study included patients with CHB-related cirrhosis who initiated NA therapy between March 2008 and June 2020 and were followed through May 2024. Eligible patients underwent baseline and on-treatment upper endoscopy. Patients with baseline HRV, prior variceal ligation, use of nonselective β-blockers, other viral hepatitis, alcohol overuse, or malignancy were excluded. The cumulative incidence of HRV and adjusted subdistribution hazard ratios (aSHRs) were estimated using competing-risk methods. A point-based risk prediction model was derived from multivariable regression coefficients.

Results

Among the 110 included patients, 14 (12.7%) developed HRV over a median follow-up of 3.6 years (IQR, 2.0–5.6). In multivariable analysis, fibrosis-4 (FIB-4) ≥4.0 (aSHR 9.77; 95% CI, 1.45–65.7), coexisting metabolic dysfunction-associated steatotic liver disease (MASLD) (aSHR 6.37; 95% CI, 1.84–22.0), and albumin-bilirubin (ALBI) grade >1 (aSHR 3.02; 95% CI, 1.21–7.55) were independently associated with incident HRV and were assigned 3, 2, and 1 point, respectively, in the prediction model. At 3 years, the cumulative incidence of HRV was 1.5% (95% CI, 0–4.5) in the low-risk group (0–3 points) and 21.4% (95% CI, 8.0–34.8) in the high-risk group (4–6 points) (p = 0.001).

Conclusion

MASLD, FIB-4, and ALBI grade predict incident HRV in NA-treated CHB cirrhosis, enabling risk-stratified endoscopic surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisEsophageal and Gastric VaricesHepatitis B, ChronicNucleosidesAntiviral AgentsHumansFemaleRetrospective StudiesMaleMiddle AgedIncidenceRisk Factors

Stichwörter der Autor:innen

Esophageal varicesFibrosisHepatitis B virusLiver cirrhosis

Substanzen

NucleosidesAntiviral Agents

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
  • School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, tylee@vghtc.gov.tw.
  • School of Medicine, Chung Shan Medical University, Taichung, Taiwan, tylee@vghtc.gov.tw.

Zitieren

APA

Chiu, Y. C., Tsai, H. J., Chen, C. C., Lin, Y. C., Lee, S. W., & Lee, T. Y. (2026). Predictors of Incident High-Risk Varices in Patients with Hepatitis B-Related Cirrhosis Receiving Nucleos(t)ide Analog Therapy. Digestive Diseases, 1-10. https://doi.org/10.1159/000553519

Vancouver

Chiu YC, Tsai HJ, Chen CC, Lin YC, Lee SW, Lee TY. Predictors of Incident High-Risk Varices in Patients with Hepatitis B-Related Cirrhosis Receiving Nucleos(t)ide Analog Therapy. Digestive Diseases. 2026:1-10. doi:10.1159/000553519

BibTeX
@article{Chiu2026,
  author = {Chiu, Yu-Chia and Tsai, Hsin-Ju and Chen, Chia-Chang and Lin, Ying-Cheng and Lee, Shou-Wu and Lee, Teng-Yu},
  title = {Predictors of Incident High-Risk Varices in Patients with Hepatitis B-Related Cirrhosis Receiving Nucleos(t)ide Analog Therapy},
  journal = {Digestive Diseases},
  year = {2026},
  pages = {1--10},
  doi = {10.1159/000553519}
}
Kostenlos starten →